000 | 01986 a2200517 4500 | ||
---|---|---|---|
005 | 20250516073443.0 | ||
264 | 0 | _c20130212 | |
008 | 201302s 0 0 eng d | ||
022 | _a1475-2662 | ||
024 | 7 |
_a10.1017/S0007114511007227 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPanaro, Maria Antonietta | |
245 | 0 | 0 |
_aAnti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. _h[electronic resource] |
260 |
_bThe British journal of nutrition _cNov 2012 |
||
300 |
_a1623-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadverse effects |
650 | 0 | 4 | _aCaco-2 Cells |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 |
_aColonic Neoplasms _ximmunology |
650 | 0 | 4 |
_aDietary Supplements _xadverse effects |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aEnterocytes _xcytology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aI-kappa B Proteins _xmetabolism |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xdiet therapy |
650 | 0 | 4 | _aLipopolysaccharides |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aProtein Processing, Post-Translational |
650 | 0 | 4 | _aProteolysis |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aResveratrol |
650 | 0 | 4 |
_aStilbenes _xadverse effects |
650 | 0 | 4 |
_aToll-Like Receptor 4 _xgenetics |
700 | 1 | _aCarofiglio, Vito | |
700 | 1 | _aAcquafredda, Angela | |
700 | 1 | _aCavallo, Pasqua | |
700 | 1 | _aCianciulli, Antonia | |
773 | 0 |
_tThe British journal of nutrition _gvol. 108 _gno. 9 _gp. 1623-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0007114511007227 _zAvailable from publisher's website |
999 |
_c21467174 _d21467174 |